Texas Administrative Code
Title 25 - HEALTH SERVICES
Part 1 - DEPARTMENT OF STATE HEALTH SERVICES
Chapter 404 - PROTECTION OF CLIENTS AND STAFF-MENTAL HEALTH SERVICES
Subchapter E - RIGHTS OF PERSONS RECEIVING MENTAL HEALTH SERVICES
Section 405.105 - Indications and Contraindications for the Use of Electroconvulsive Therapy (ECT)

Current through Reg. 49, No. 38; September 20, 2024

(a) The major indications for the therapeutic use of ECT are major mood disorders. ECT may be considered for some other disorders, with appropriate consideration of the risk/benefit ratio.

(b) The major contraindications to the therapeutic use of ECT are as follows:

(1) absolute space-occupying intracranial pathology;

(2) relative, requiring clinical consideration:
(A) cardiovascular disease, including arrhythmias, myocardial disease, or coronary artery disease;

(B) diseases which render a patient likely to suffer hemorrhage, including peptic ulcer, subdural hematoma, and aortic aneurysm;

(C) degenerative diseases of the central nervous system;

(D) glaucoma although it is recognized that intraocular pressure is not increased by ECT, and is, in fact, reduced during the seizure period, medications used adjunctively to the treatment may result in increased intraocular pressure. For patients with glaucoma, consideration should be given to pretreatment with physostigmine;

(E) severe orthopedic disability.

Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.